Beijing, China

Xiaoding Hou


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Xiaoding Hou: A Pioneer in Cancer Treatment

Introduction: Xiaoding Hou, based in Beijing, China, is a prominent inventor known for his contributions to the field of pharmaceuticals. With a keen focus on developing compounds that can combat serious health conditions, Xiaoding has made significant strides through his innovative research.

Latest Patents: Xiaoding holds a patent for a novel compound named 2-(1H-pyrazol-3-yl) phenol and its use in the treatment and prevention of cancers. This patent encompasses the compound itself, as well as its pharmaceutically acceptable salts, stereoisomers, ethers, esters, prodrugs, and solvates. This innovation represents hope for many, as it targets cancer therapies that can enhance patient outcomes.

Career Highlights: Currently, Xiaoding is affiliated with Beijing Jialin Pharmaceutical Inc., where he continues to refine his research and contribute to the development of effective pharmaceutical solutions. His role at this company allows him to work on cutting-edge projects that aim to revolutionize cancer treatment methodologies.

Collaborations: In his professional journey, Xiaoding collaborates with talented colleagues such as Wei He and E Liang. Together, they bring diverse expertise and experience to the table, fostering an environment of creativity and innovation that is crucial for breakthrough advancements in health sciences.

Conclusion: Xiaoding Hou is a trailblazer in the realm of cancer treatment innovations. His patent and ongoing research efforts at Beijing Jialin Pharmaceutical Inc. showcase his dedication to tackling one of the most pressing medical challenges of our time. Through his work, Xiaoding continues to inspire the next generation of inventors and researchers committed to making a difference in the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…